farkas spinal decompression
[Home] [Dr Farkas] [About Us] [Testimonials] [Links] [Contact Us]

MayoClinicSTudy75Doctor John Leslie, MD, Mayo Clinic, Arizona, and other noted doctors, Pilot on the Effectivieness and Safety of Non-Surgical Spinal Decompression. 

The following is the Abstract of that Report. To receive your free copy of the entire Report, please contact us and we will mail it to you.

ABSTRACT

Objective: Prospective, multi-center, phase II, nonrandomized, clinical study to evaluate the effectiveness and safety of the Axiom Worldwide DRX9000 for active treatment of chronic LBP unitizing a standardized clinical research multimodal protocol. 

Methods: 20 patients with chronic LBP based on a diagnosis of musculoskeletal or mechanical LBP, herniated discs, bulging or protruding discs, degenerative disc, pain from failed back surgery more than 6 months previously, posterior facet syndrome of sciatica underwent a series of 20 DRX treatments (28 minutes each) for 6 weeks with 5 sessions the first week tapering to 1 session/wk. Treatment multimodal protocol included ice after DRX sessions, lumbar stretching exercises, and adjunct analgesics as required. Assessments of pain, analgesic use, functionality, satisfaction, activities of daily living and safety were collected through examinations, questionnaires and patient diaries.

Results: 18 evaluable subjects (33.3% female, 83.3% white, mean age 46.6, 77.8% employed) had a change in mean pain score per week of 6.4 (n=18) on a 0 to 10 scale ( 0 = no pain 10 = worst pain) at baseline that decreased to 0.8 (n=17) at week 6. Patients reported a mean 88.9% (16 out of 18) improvement in back pain, better function as measured by activities of daily living. On a 0 to 10 scale ( 0 = no satisfied 10 = very satisfied) patients treated the DRX9000 an 8.1. No patient required any invasive therapies (e.g., epidural injections, surgery).

Conclusion: Overall, patients’ pain improved immediately after DRX treatment, requiring fewer analgesics, with better function. There were no safety issues identified with the multimodal treatment routine. Non-treatment of control groups were not included making efficacy outcome versus placebo or spontaneous recovery difficult to determine. Randomized double-blind or comparative long-term outcome trials are needed to further prove the efficacy of the DRX9000 non-surgical spinal decompression system for the routine treatment of chronic LBP.

Disclosure: This study was funded by Axiom Worldwide.

 

To receive your free copy of Doctor Leslie’s complete study by mail, click here.

phone -248-399-9355 * Contact@FarkasSpinalAid.com  * fax -248-399-8644

[Home] [Dr Farkas] [About Us] [Testimonials] [Yochum Report] [Stanford University Report] [Mayo Clinic Report] [Request Study] [Links] [Contact Us]